The presence of bone metastases in esophageal cancer indicates that the cancerous lesion has progressed to an advanced stage, and the survival time is usually about three months.
Esophageal cancer is a relatively common malignant tumor with insidious onset and basically no obvious symptoms in the early stage, and most of them have progressed to the middle and late stage when patients have symptoms and are diagnosed after examination.
If esophageal cancer can be detected and treated early, the survival time and quality of survival after surgery is much higher than that of patients in the middle and late stages. Once metastases of cancer cells appear, it suggests that the disease has entered advanced stage and survival time can only be calculated by days. In particular, when bone metastases appear, it indicates massive cancer infiltration, which is a serious disease of advanced esophageal cancer, and the survival time is usually not more than three months.
The treatment of esophageal cancer patients with bone metastases focuses on reducing the patient’s pain and improving the patient’s survival quality. Nutritional support can be provided through extra-venous total nutrition, and strong analgesics such as morphine and dulcolax can be used to reduce the patient’s pain. Avoid overuse of therapeutic measures such as chemotherapy to maximize the patient’s survival time and quality of life.